HomeCompareLGIQ vs MRK

LGIQ vs MRK: Dividend Comparison 2026

LGIQ yields 200000.00% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 LGIQ wins by $4.911780474428384e+29M in total portfolio value
10 years
LGIQ
LGIQ
● Live price
200000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.911780474428384e+29M
Annual income
$490,695,411,370,591,700,000,000,000,000,000,000.00
Full LGIQ calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — LGIQ vs MRK

📍 LGIQ pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodLGIQMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, LGIQ + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
LGIQ pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

LGIQ
Annual income on $10K today (after 15% tax)
$17,000,000.00/yr
After 10yr DRIP, annual income (after tax)
$417,091,099,665,002,940,000,000,000,000,000,000.00/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, LGIQ beats the other by $417,091,099,665,002,940,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of LGIQ + MRK for your $10,000?

LGIQ: 50%MRK: 50%
100% MRK50/50100% LGIQ
Portfolio after 10yr
$2.455890237214192e+29M
Annual income
$245,347,705,685,295,860,000,000,000,000,000,000.00/yr
Blended yield
99.90%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

LGIQ
No analyst data
Altman Z
-320.8
Piotroski
2/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

LGIQ buys
0
MRK buys
0
No recent congressional trades found for LGIQ or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricLGIQMRK
Forward yield200000.00%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$4.911780474428384e+29M$56.8K
Annual income after 10y$490,695,411,370,591,700,000,000,000,000,000,000.00$9,798.13
Total dividends collected$4.911464459982279e+29M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: LGIQ vs MRK ($10,000, DRIP)

YearLGIQ PortfolioLGIQ Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$20,010,700$20,000,000.00$11,206$366.19+$20.00MLGIQ
2$37,424,589,019$37,403,177,570.09$12,650$502.35+$37424.58MLGIQ
3$65,416,215,188,220$65,376,170,877,969.18$14,407$694.19+$65416215.17MLGIQ
4$106,868,230,495,008,900$106,798,235,144,757,520.00$16,585$967.82+$106868230494.99MLGIQ
5$163,172,871,735,896,870,000$163,058,522,729,267,200,000.00$19,342$1,363.89+$163172871735896.84MLGIQ
6$232,854,599,801,468,860,000,000$232,680,004,828,711,460,000,000.00$22,913$1,947.19+$232854599801468864.00MLGIQ
7$310,570,858,137,017,100,000,000,000$310,321,703,715,229,540,000,000,000.00$27,662$2,823.89+$310570858137017057280.00MLGIQ
8$387,148,154,301,613,200,000,000,000,000$386,815,843,483,406,600,000,000,000,000.00$34,159$4,173.35+$3.871481543016132e+23MLGIQ
9$451,061,749,763,281,040,000,000,000,000,000$450,647,501,238,178,360,000,000,000,000,000.00$43,337$6,308.80+$4.510617497632811e+26MLGIQ
10$491,178,047,442,838,440,000,000,000,000,000,000$490,695,411,370,591,700,000,000,000,000,000,000.00$56,776$9,798.13+$4.911780474428384e+29MLGIQ

LGIQ vs MRK: Complete Analysis 2026

LGIQStock

Logiq, Inc. provides e-commerce solutions in the European Union, Southeast Asia, Africa, South Korea, and North America. It provides AppLogiq, a Platform-as-a-Service platform that enables small and medium sized businesses (SMBs) to establish their point-of-presence on the web. The company also offers DataLogiq, a digital marketing analytics business unit that offers proprietary data management, audience targeting, and other digital marketing services to enhance an SMB's discovery and branding within the e-commerce landscape. In addition, it offers PayLogiq, an e-wallet for mobile payments; and GoLogiq, a food delivery application. The company was formerly known as Weyland Tech Inc. and changed its name to Logiq, Inc. in September 2020. Logiq, Inc. was incorporated in 2004 and is headquartered in New York, New York.

Full LGIQ Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this LGIQ vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

LGIQ vs SCHDLGIQ vs JEPILGIQ vs OLGIQ vs KOLGIQ vs MAINLGIQ vs JNJLGIQ vs ABBVLGIQ vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.